Miroslav Hodek

Miroslav Hodek

Auto-generated profile, based on publicly available information

Miroslav Hodek

Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Czech Republic

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2019 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
KHKamila Hladíková
Kamila Hladíková
VKVladimír Koucký
Vladimír Koucký
JBJan Bouček
Jan Bouček
JLJan Laco
Jan Laco
MGMarek Grega
Marek Grega
AFAnna Fialová
Anna Fialová
Background Standard treatment of oropharyngeal squamous cell carcinoma (OPSCC) is associated with high morbidity, whereas immunotherapeutic approaches using PD-1:PD-L1 checkpoint blockade only show moderate response rates in OPSCC patients. Therefore, a better stratification of patients and the development of novel therapeutic protocols are crucially needed. The importance of tumor-infiltrating B cells (TIL-Bs) in shaping antitumor immunity remains unclear; therefore, we analyzed frequency, phenotype, prognostic value and possible roles of TIL-Bs in OPSCC. Methods We utilized transcriptomic analysis of immune response-related genes in 18 OPSCC samples with respect to human papillomavirus (HPV) status. The density and localization of CD20+, CD8+ and DC-LAMP+ cells were subsequently analyzed in 72 tissue sections of primary OPSCC samples in relation to patients’ prognosis. The immunohistochemical approach was supplemented by flow cytometry-based analysis of phenotype and functionality of TIL-Bs in freshly resected primary OPSCC tissues. Results We observed significantly higher expression of B cell-related genes and higher densities of CD20+ B cells in HPV-associated OPSCC samples. Interestingly, CD20+ TIL-Bs and CD8+ T cells formed non-organized aggregates with interacting cells within the tumor tissue. The densities of both intraepithelial CD20+ B cells and B cell/CD8+ T cell interactions showed prognostic significance, which surpassed HPV positivity and CD8+ TIL density in stratification of OPSCC patients. High density of TIL-Bs was associated with an activated B cell phenotype, high CXCL9 production and high levels of tumor-infiltrating CD8+ T cells. Importantly, the abundance of direct B cell/CD8+ T cell interactions positively correlated with the frequency of HPV16-specific CD8+ T cells, whereas the absence of B cells in tumor-derived cell cultures markedly reduced CD8+ T cell survival. Conclusions Our results indicate that high abundance of TIL-Bs and high density of direct B cell/CD8+ T cell interactions can predict patients with excellent prognosis, who would benefit from less invasive treatment. We propose that in extensively infiltrated tumors, TIL-Bs might recruit CD8+ T cells via CXCL9 and due to a highly activated phenotype contribute by secondary costimulation to the maintenance of CD8+ T cells in the tumor microenvironment.

27 August 2009 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JPJiří Petera
Jiří Petera
RSRenata Soumarová
Renata Soumarová
JRJana Růžičková
Jana Růžičková
RNRenata Neumanová
Renata Neumanová
LDLadislav Dušek
Ladislav Dušek
MVMilan Vošmik
Milan Vošmik

1 May 2020 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
MVMilan Vošmik
Milan Vošmik
MHMiroslav Hodek
Miroslav Hodek
DBDavid Buka
David Buka
PSPetra Sýkorová
Petra Sýkorová
JGJakub Grepl
Jakub Grepl
ISIgor Sirak
Igor Sirak
With a development of radiotherapeutic techniques, availability of radiotherapy data on cardiotoxicity, and slowly improving esophageal cancer outcomes, an increasing emphasis is placed on the heart protection in radiation treated esophageal cancer patients. Radiation induced heart complications encompass mainly pericardial disease, cardiomyopathy, coronary artery atherosclerosis, valvular heart disease, and arrhythmias. The most frequent toxicity is pericardial effusion which is usually asymptomatic in the majority of patients. The use of modern radiotherapy techniques is expected to reduce the risk of cardiotoxicity, although this expectation has to be confirmed by clinical data.

6 June 2016 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
MHMiroslav Hodek
Miroslav Hodek
ISIgor Sirak
Igor Sirak
AFAlexander Ferko
Alexander Ferko
JÖJúlius Örhalmi
Július Örhalmi
EHEva Hovorková
Eva Hovorková
MVMilan Vošmik
Milan Vošmik


1 May 2012 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
PPPetr Paluska
Petr Paluska
JHJosef Hanus
Josef Hanus
JSJana Sefrova
Jana Sefrova
LRLucie Rouskova
Lucie Rouskova
JGJakub Grepl
Jakub Grepl
JPJiri Petera
Jiri Petera
To assess target volume coverage during prostate image-guided radiotherapy based on bony anatomy alignment and to assess possibility of safety margin reduction. Implementation of IGRT should influence safety margins. Utilization of cone-beam CT provides current 3D anatomic information directly in irradiation position. Such information enables reconstruction of the actual dose distribution. Seventeen prostate patients were treated with daily bony anatomy image-guidance. Cone-beam CT (CBCT) scans were acquired once a week immediately after bony anatomy alignment. After the prostate, seminal vesicles, rectum and bladder were contoured, the delivered dose distribution was reconstructed. Target dose coverage was evaluated by the proportion of the CTV encompassed by the 95% isodose. Original plans employed a 1 cm safety margin. Alternative plans assuming a smaller 7 mm margin between CTV and PTV were evaluated in the same way. Rectal and bladder volumes were compared with the initial ones. Rectal and bladder volumes irradiated with doses higher than 75 Gy, 70 Gy, 60 Gy, 50 Gy and 40 Gy were analyzed. In 12% of reconstructed plans the prostate coverage was not sufficient. The prostate underdosage was observed in 5 patients. Coverage of seminal vesicles was not satisfactory in 3% of plans. Most of the target underdosage corresponded to excessive rectal or bladder filling. Evaluation of alternative plans assuming a smaller 7 mm margin revealed 22% and 11% of plans where prostate and seminal vesicles coverage, respectively, was compromised. These were distributed over 8 and 7 patients, respectively. Sufficient dose coverage of target volumes was not achieved for all patients. Reducing of safety margin is not acceptable. Initial rectal and bladder volumes cannot be considered representative for subsequent treatment.